Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBT-I vs Lemborexant for Chronic Insomnia
NCT06779149Recruiting
- Sponsor
- Université Laval
- Start
- Apr 2025
- Primary completion
- Feb 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of lemborexant in insomnia disorder (3 arms), sponsored by Université Laval. Primary endpoint: Insomnia Symptom Severity at Month 6. Started Apr 2025; status: recruiting.
02
Drugs
lemborexant
03
Conditions
insomnia disorder
Beyond the preview
Go deeper on NCT06779149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06779149.